Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 7/20 | 0.47 |
| ▸ | TACR1 | P25103 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 4/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9609736 | 0.90 | CASR (0.38) | CASRTACR1CYP1A2CA1CA2 | |
| SCHEMBL9609745 | 0.87 | CASR (0.37) | CASRTACR1CA1CA2CA7 | |
| SCHEMBL9609711 | 0.80 | MMP12 (0.39) | ALDH1A1 | |
| SCHEMBL9609729 | 0.80 | MC5R (0.41) | CASRCYP1A2CYP2A6 | |
| SCHEMBL9609749 | 0.80 | CA1 (0.36) | CYP1A2CA1CA2CA7CA9 | |
| SCHEMBL12187709 | 0.78 | CASR (0.51) | CASRTACR1CYP1A2CYP2A6CA1 | |
| SCHEMBL13029161 | 0.77 | CA1 (0.37) | CASRTACR1CYP1A2CA1CA2 | |
| SCHEMBL9609688 | 0.76 | ADRB2 (0.58) | ALDH1A1 | |
| SCHEMBL9609691 | 0.76 | KDM4E (0.39) | CYP1A2CA1CA2CA7CA9 | |
| SCHEMBL8140787 | 0.74 | CYP1A2 (0.52) | CYP1A2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921243-B2 | Fabrics comprising a photocatalyst to produce singlet oxygen from ambient oxygen | VENTANA RESEARCH CORPORATION | 2014-12-30 | — | — | US | disclosed |
| US-8481446-B2 | Chemically-resistant coating composition | VENTANA RESEARCH CORPORATION | 2013-07-09 | — | — | US | disclosed |
| US-20120135651-A1 | Fabrics Comprising a Photocatalyst to Produce Singlet Oxygen from Ambient Oxygen | VENTANA RESEARCH CORPORATION | 2012-05-31 | — | — | US | disclosed |
| US-20100279850-A1 | CHEMICALLY-RESISTANT COATING COMPOSITION | VENTANA RESEARCH CORPORATION | 2010-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100279850-A1 | CHEMICALLY-RESISTANT COATING COMPOSITION | DNMT1, VCL, DNMT3L | CASR 4029/4885TACR1 3554/4885CYP1A2 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.